Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch - Sevre-Long 120 mg, Kapseln retard | | 53952 | | 04 | | Sevre-Long 120 mg | | Kapseln retard | | N02AA01 | | Morphin | | 30.01.1997 | | |
| Composition | morphini sulfas pentahydricus 120 mg corresp. morphinum 90.25 mg, oleum vegetabile hydrogenatum, macrogolum 6000, talcum, magnesii stearas, Kapselhülle: E 132, E 172 (nigrum), E 172 (flavum), E 171, natrii laurilsulfas corresp. natrium 0.012 mg, gelatina, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro capsula. | Packungsbestandteile | | Capsules retard | | | Principe actif | Concentr. |
---|
Morphine Sulfate Pentahydrate | 120 mg correspond Morphine 90.25 mg |
| BAG: Principe actif | Concentr. |
---|
| 120 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
| | | | | | | | Kapselhülle | | | color. | | | color. | Gelatina | | | | | Drucktinte | Macrogol | 6000 | | | | | | | | | | | | | | Propylenglycol | | | Talcum | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
001 | 100 Gélule(s) | 172.64 | 204.15 | A+ | LS | Non | 046 | 30 Gélule(s) | 54.52 | 75.70 | A+ | LS | Non |
|
|